LifeCell Launches 'Transformational' Newborn Screening Program

/ --
~ World's First to launch Integrated DNA testing for more accurate results & reduced false positives ~
(Logo: https://mma.prnewswire.com/media/774846/LifeCell_Logo.jpg )
Ishaan Khanna, CEO of Diagnostic & BioBank Divisions, LifeCell International said, "As a leader we always bring the first and best to the country and "RightStart" is another milestone achievement. For the first time over 50 conditions can be tested with 'RightStart's integrated DNA testing in the country with a faster throughput and higher accuracy of test results."
Molecular confirmation of the disorder flagged off in the RightStart NBS is a new initiative that will help to accurately confirm the diagnosis for the families. Testing on the stored blood spot for confirmation decreases family anxiety and repeated clinic visits and resampling."

Dr Vrajesh Udani, Consultant in Child Neurology and Epilepsy, Hinduja Hospital & Saifee Hospital, Mumbai added, "RightStart is an initiative by LifeCell where a positive report on newborn screening is automatically subjected to a confirmatory test. This will eliminate false positives which is very welcome. False positive reports in newborn screening cause unwanted concerns and sometimes unwarranted treatments. I'm happy RightStart will help to reduce such false alarms."

Reference: 1. https://www.aphl.org/conferences/proceedings/Documents/2016/NBS-Genetic-Testing-Symposium/28Green.pdf
About LifeCell